Prenetics Global Ltd is a consumer health and wellness company offering nutrition and longevity products through its flagship brand, IM8. It offers science-backed daily nutrition and longevity products distributed directly to consumers across multiple countries. The company's products are developed with scientific input and are subject to third-party quality certifications.
Last trade$16.03
Day change+$0.545 (+3.52%)
Day range$15.23 – $16.24
Volume142,388
Market cap$302M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for PRE.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
No quarterly
income statement data was found for PRE.
Recent news
Company coverage with links to the original publishers.
Prenetics Global Limited (NASDAQ: PRE) announced that CEO Danny Yeung and CFO Brian Rosin purchased $1.0 million in company shares during August 2026, bringing cumulative leadership investment to $3.75 million since November 2025. The purchases follow strong Q2 2026 results with total revenue up 288% YoY to $46.5 million, IM8 revenue reaching $45.0 million (up 359% YoY), and the company achieving its first month of positive consolidated Adjusted Free Cash Flow in July. Prenetics raised FY 2026 revenue guidance to $220-230 million and introduced FY 2027 guidance of over $400 million.
Prenetics Global Limited announced a $1 billion growth financing deal with General Catalyst's Customer Value Fund to accelerate IM8's marketing spend. The company raised its full-year 2026 revenue guidance to $210-220 million (from $190-210 million) and projects $300 million annualized run-rate by year-end 2026 and $400+ million in full-year 2027 revenue. IM8, co-founded by David Beckham, has become the fastest-growing premium supplement brand ever, delivering 200,000 servings daily across 43 countries with strong unit economics ($1.44 gross profit return per $1 acquisition spend).
Prenetics Global Limited's IM8 brand has partnered with Superpower to create an integrated health platform combining clinical-grade supplements with comprehensive blood biomarker testing. IM8 90-day subscribers can access Superpower's annual blood testing membership for $49 (75% discount), while Superpower members gain access to IM8's Daily Ultimate Essentials at preferred rates. The partnership aims to provide measurable proof of supplement efficacy through a closed-loop testing and supplementation system.
The global personalized nutrition market is projected to grow from $15.79 billion in 2025 to $30.94 billion by 2030 at a 14.4% CAGR. Digital tools and active measurement technologies are the fastest-growing segments, while Asia Pacific emerges as a high-growth regional hub driven by expanding middle class, rising lifestyle diseases, and rapid digital health adoption.
Prenetics Global Limited completed the sale of its 35% equity interest in Insighta to Tencent for $70 million in cash, bringing total adjusted liquidity to $171.1 million. The company operates with zero debt and plans to use the proceeds to accelerate IM8's global expansion. IM8, co-founded with David Beckham, has achieved over $100 million in annualized recurring revenue within 11 months and is sold in more than 30 countries.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
Ex-dividend
Amount / share
Pay date
Type
Feb 17, 2016
$10.50
Mar 1, 2016
unknown
Nov 4, 2015
$10.50
Dec 1, 2015
recurring
Aug 5, 2015
$10.50
Sep 1, 2015
recurring
May 6, 2015
$10.50
Jun 1, 2015
recurring
Feb 11, 2015
$10.50
Feb 27, 2015
recurring
Stock splits
Historical share-structure events and their execution dates.